Aigen Investment Management LP lowered its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 65.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,443 shares of the technology company's stock after selling 8,340 shares during the quarter. Aigen Investment Management LP's holdings in Amdocs were worth $389,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in DOX. State Board of Administration of Florida Retirement System grew its position in Amdocs by 7.9% during the first quarter. State Board of Administration of Florida Retirement System now owns 166,927 shares of the technology company's stock valued at $16,030,000 after buying an additional 12,178 shares during the period. Boston Trust Walden Corp boosted its stake in shares of Amdocs by 17.0% during the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company's stock worth $48,803,000 after purchasing an additional 89,726 shares during the period. SG Americas Securities LLC boosted its holdings in Amdocs by 402.4% during the 2nd quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company's stock valued at $12,230,000 after acquiring an additional 124,122 shares during the period. Sargent Investment Group LLC bought a new position in shares of Amdocs in the second quarter worth about $289,000. Finally, Acadian Asset Management LLC grew its stake in Amdocs by 22.7% in the 1st quarter. Acadian Asset Management LLC now owns 1,395,894 shares of the technology company's stock worth $126,119,000 after acquiring an additional 258,343 shares in the last quarter. Institutional investors own 92.02% of the company's stock.
Amdocs Stock Down 2.0 %
Amdocs stock traded down $1.73 during trading on Friday, reaching $83.98. The stock had a trading volume of 943,960 shares, compared to its average volume of 683,137. The stock has a market cap of $9.87 billion, a PE ratio of 19.81, a P/E/G ratio of 1.42 and a beta of 0.74. The business has a 50 day moving average price of $88.18 and a 200 day moving average price of $83.96. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.21.
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs's dividend payout ratio is currently 45.28%.
Analysts Set New Price Targets
DOX has been the subject of several recent research reports. Stifel Nicolaus started coverage on Amdocs in a research report on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 price target for the company. StockNews.com downgraded Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday. Oppenheimer upped their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday. Finally, Barclays dropped their target price on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $101.83.
Get Our Latest Stock Report on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.